EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Complexity of the Genetic Background of Oncogenesis in Ovarian Cancer—Genetic Instability and Clinical Implications

Marek Murawski, Adam Jagodziński, Aleksandra Bielawska-Pohl iD, Aleksandra Klimczak iD

Cells · 2024

DOI: 10.3390/cells13040345 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Marek Murawski und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1st Clinical Department of Gynecology and Obstetrics, Wroclaw Medical University, 50-367 Wroclaw, Poland. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer is a leading cause of death among women with gynecological cancers, and is often diagnosed at advanced stages, leading to poor outcomes. This review explores genetic aspects of high-grade serous, endometrioid, and clear-cell ovarian carcinomas, emphasizing personalized treatment approaches. Specific mutations such as TP53 in high-grade serous and BRAF/KRAS in low-grade serous carcinomas highlight the need for tailored therapies. Varying mutation prevalence across subtypes, including BRCA1/2, PTEN, PIK3CA, CTNNB1, and c-myc amplification, offers potential therapeutic targets. This review underscores TP53’s pivotal role and advocates p53 immunohistochemical staining for mutational analysis. BRCA1/2 mutations’ significance as genetic risk factors and their relevance in PARP inhibitor therapy are discussed, emphasizing the importance of genetic testing. This review also addresses the paradoxical better prognosis linked to KRAS and BRAF mutations in ovarian cancer. ARID1A, PIK3CA, and PTEN alterations in platinum resistance contribute to the genetic landscape. Therapeutic strategies, like restoring WT p53 function and exploring PI3K/AKT/mTOR inhibitors, are considered. The evolving understanding of genetic factors in ovarian carcinomas supports tailored therapeutic approaches based on individual tumor genetic profiles. Ongoing research shows promise for advancing personalized treatments and refining genetic testing in neoplastic diseases, including ovarian cancer. Clinical genetic screening tests can identify women at increased risk, guiding predictive cancer risk-reducing surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCystadenocarcinoma, SerousFemaleHumansBRCA1 ProteinTumor Suppressor Protein p53Proto-Oncogene Proteins B-rafPhosphatidylinositol 3-KinasesProto-Oncogene Proteins p21(ras)BRCA2 ProteinCarcinogenesisCell Transformation, NeoplasticClass I Phosphatidylinositol 3-KinasesGenetic Background

Stichwörter der Autor:innen

ARID1A mutationsBRAF mutationsBRCA1 mutationsBRCA2 mutationsCTNNB1 mutationsPIK3CA mutationsPTEN mutationsRAS mutationsRRSOTP53 mutationsc-myc amplificationgenetic instabilityoncogenesisovarian cancer

Substanzen

BRCA1 protein, humanBRCA1 ProteinTumor Suppressor Protein p53Proto-Oncogene Proteins B-rafPhosphatidylinositol 3-KinasesProto-Oncogene Proteins p21(ras)BRCA2 protein, humanBRCA2 ProteinClass I Phosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • 1st Clinical Department of Gynecology and Obstetrics, Wroclaw Medical University, 50-367 Wroclaw, Poland.
  • Laboratory of Biology of Stem and Neoplastic Cells, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.

ORCID-Profile: Aleksandra Bielawska-Pohl, Aleksandra Klimczak

Zitieren

APA

Murawski, M., Jagodziński, A., Bielawska-Pohl, A., & Klimczak, A. (2024). Complexity of the Genetic Background of Oncogenesis in Ovarian Cancer—Genetic Instability and Clinical Implications. Cells. https://doi.org/10.3390/cells13040345

Vancouver

Murawski M, Jagodziński A, Bielawska-Pohl A, Klimczak A. Complexity of the Genetic Background of Oncogenesis in Ovarian Cancer—Genetic Instability and Clinical Implications. Cells. 2024. doi:10.3390/cells13040345

BibTeX
@article{Murawski2024,
  author = {Murawski, Marek and Jagodziński, Adam and Bielawska-Pohl, Aleksandra and Klimczak, Aleksandra},
  title = {Complexity of the Genetic Background of Oncogenesis in Ovarian Cancer—Genetic Instability and Clinical Implications},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13040345}
}
Kostenlos starten →